drugset
drugset / Trial / NCT00848536

Efficacy Study of Travoprost APS Versus TRAVATAN

NCT00848536 ↗

Phase 3 Completed 371 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

A Multi-Center Double-masked Study of the Safety and Efficacy of Travoprost APS Compared to TRAVATAN in Patients with Open-angle Glaucoma or Ocular Hypertension

Timeline

Start
2009-03
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Travoprost Other / unclassified 0.004 % Topical

Indications

ocular hypertension open-angle glaucoma